vimarsana.com

Page 53 - சீரம் நிறுவனம் ஆஃப் இந்தியா லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

What we know about the Oxford-AstraZeneca Covid vaccine which healthcare workers will soon receive

Another 500 000 doses are expected next month, with healthcare workers being prioritised The vaccine has already been approved by various regulators and is currently being rolled out in other countries Health Minister Zweli Mkhize announced on Thursday that South Africa will be receiving one million Covid-19 vaccine doses in January, followed by an additional 500 000 in February from the Serum Institute of India Ltd. which is producing the vaccine developed by AstraZeneca and the University of Oxford, News24 reported. “We are all happy that the Serum Institute of India and AstraZeneca vaccine has already been approved by various regulators and is being rolled out. SAHPRA is applying reliance on that regulatory framework, Mkhize said.

Who s On the Hook If Vaccines Go Wrong? - The Washington Post

South Africa to Get First Vaccines for Health Workers This Month

South Africa to Get Vaccines for Health Workers This Month Bloomberg 1/7/2021 Paul Vecchiatto and Janice Kew © Photographer: VINCENZO PINTO/AFP Filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate. (Bloomberg) South Africa struck a deal to receive the country’s first coronavirus vaccines this month and next, the earliest phase of a plan the government says will inoculate two-thirds of the population by the end of 2021. An initial 1.5 million doses will come from The Serum Institute of India Ltd., which is producing the version developed by AstraZeneca Plc and the University of Oxford, Health Minister Zweli Mkhize said in a statement on Thursday. They will be reserved for health workers, and negotiations are ongoing with other manufacturers about further supplies, he said.

Coronavirus news highlights: Karnataka reports 784 new Covid-19 cases, 6 deaths

Cases of new UK mutant COVID strain go up to 73 in India The number of people who have tested positive for the new UK variant of SARS-CoV-2 in the country has climbed to 73, the Union health ministry said on Wednesday. These cases include the 58 which were announced by the ministry till Tuesday. The total number of cases infected with the new strain of the novel coronavirus first reported in the UK now stands at 73, the ministry said. All these people have been kept in single room isolation in designated healthcare facilities by respective state governments, the ministry had said on Tuesday.

Who s On the Hook If COVID-19 Vaccines Go Wrong?: Viewpoint

Who’s On the Hook If COVID-19 Vaccines Go Wrong?: Viewpoint By Anjani Trivedi, Bloomberg Opinion and Andy Mukherjee, Bloomberg Opinion | January 7, 2021 The COVID-19 vaccines are here and distribution has begun. But what if something goes wrong? Whether it’s a loss of income, hefty medical bills or other serious adverse effects from getting a shot, someone has to pick up the tab, be it vaccine manufacturers or governments. In the past, so-called liability shields have given companies cover to produce effective treatments quickly without legal exposure. But it’s a risky endeavor for countries to absorb full responsibility for highly novel products, developed and licensed at lightning speed. Especially when every man, woman and, eventually, child will need to be injected.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.